We are pleased to announce that effective October 6, 2014 Anita Carrie has joined PDCI Market Access Inc as a Senior Consultant as part of the HTA and Clinical Evaluation team.
Most recently Anita has been working at the CADTH Common Drug Review (CDR) where she held several senior roles, including ... Read More
08
Oct2014
07
Oct2014
PDCI Market Access has completed its benchmarking survey on the pan-Canadian Pharmaceutical Alliance (PCPA). We received responses from manufacturers of 7 products that have successfully navigated this important reimbursement process. The purpose of the survey was to gain a better understanding of the PCPA experience from the company perspective.
The survey ... Read More
03
Oct2014
Common Drug Review patient input submission system
CADTH has added new safeguards allowing them to better track submissions automatically:
Online & email confirmations for successful uploads
Submissions can now be uploaded until midnight on the date of the specified deadline, in all Canadian time zones
2015 CADTH Symposium
CADTH is offering funding to help patient ... Read More
02
Oct2014
The Patented Medicines Prices Review Board (PMPRB) launched its new website earlier this week.
Features of the new website include:
A new look
Enhanced functionality and accessibility
A scalable, mobile-friendly format
The PMPRB stresses that the content of the website will remain the same and further information regarding these changes will be released ... Read More
02
Oct2014
The Régie de l’assurance maladie du Québec (RAMQ) has released its October update of the List of Medications, which constitutes a regulatory list of the medications covered by Québec's basic prescription drug insurance plan.
For more information and to see the list update schedule, please visit the RAMQ website.
18
Sep2014
The Patented Medicine Prices Review Board (PMPRB) recently announced that they will be launching a new website by the end of September.
Features of the new website include:
A new look
Enhanced functionality and accessibility
A scalable, mobile-friendly format
The PMPRB stresses that the content of the website will remain the same and further information ... Read More
16
Sep2014
Yesterday, thePMPRB released its Annual Reportfor the year ending December 31, 2013. The Annual Report is an extensive document that reviews all of the PMPRB´s major activities, analyses of the prices of patented medicines and of the price trends of all drugs, and reports on the R&D expenditures as reported by ... Read More
16
Sep2014
The Canadian Agency for Drugs and Technologies in Health (CADTH) revised its Guidelines for Manufacturers on Application Fees for the Common Drug Review. A draft version was circulated for stakeholder feedback in July, following which the below key changes were made:
Fees for resubmission based on new clinical information ... Read More
18
Aug2014
The C-MAP™ Canadian Drug Benefit Plans Reference Guide is the authoritative source for comprehensive and up-to-date information on Canadian reimbursement and market access for pharmaceutical market access specialists. The publication highlights each of the relevant agencies, organizations and drug plans operating in the market access and reimbursement environment in Canada. ... Read More
06
Aug2014
Direct-Acting Antivirals for Chronic Hepatitis C Genotype 1: Draft recommendations posted, feedback requested
Yesterday the Canadian Agency for Drugs and Technologies in Health (CADTH)posted on its website the draft Canadian Drug Expert Committee (CDEC) recommendations report stemming from itsrecent therapeutic review project to assess the clinical and economic impact ... Read More